CNA Financial Corporation
CNA Financial Corporation (CNA) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for CNA Financial Corporation (CNA), featuring income statements, balance sheets, and cash flow data.
CNA Financial Corporation (CNA) Income Statement & Financial Overview
Review CNA Financial Corporation CNA income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q2 2025 | Q3 2024 |
---|---|---|---|---|
Revenue | $3.63B | $3.61B | $3.61B | $3.62B |
Cost of Revenue | $0.00 | $0.00 | $0.00 | $362.00M |
Gross Profit | $3.63B | $3.61B | $3.61B | $3.26B |
Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $0.90 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Expenses | $0.00 | $3.59B | $3.61B | $2.86B |
Total Costs & Expenses | $0.00 | $3.59B | $3.61B | $3.23B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $32.00M | $32.00M | $32.00M | $32.00M |
Depreciation & Amortization | $0.00 | $16.00M | $16.00M | $17.00M |
EBITDA | $0.00 | $69.00M | $69.00M | $410.00M |
EBITDA Ratio | $0.00 | $0.02 | $0.02 | $0.11 |
Operating Income | $0.00 | $21.00M | $0.00 | $393.00M |
Operating Income Ratio | $0.00 | $0.006 | $0.00 | $0.11 |
Other Income/Expenses (Net) | $0.00 | $0.00 | $21.00M | -$32.00M |
Income Before Tax | $349.00M | $21.00M | $21.00M | $361.00M |
Income Before Tax Ratio | $0.10 | $0.006 | $0.006 | $0.10 |
Income Tax Expense | -$75.00M | $0.00 | $0.00 | $78.00M |
Net Income | $274.00M | $21.00M | $21.00M | $283.00M |
Net Income Ratio | $0.08 | $0.006 | $0.006 | $0.08 |
EPS | $1.01 | $0.08 | $0.08 | $1.04 |
Diluted EPS | $1.00 | $0.08 | $0.08 | $1.04 |
Weighted Avg Shares Outstanding | $271.30M | $271.30M | $271.30M | $271.30M |
Weighted Avg Shares Outstanding (Diluted) | $272.60M | $272.90M | $272.70M | $272.70M |
Over the last four quarters, CNA Financial Corporation achieved steady financial progress, growing revenue from $3.62B in Q3 2024 to $3.61B in Q2 2025. Gross profit stayed firm with margins at 100% in Q2 2025 versus 90% in Q3 2024. Operating income totaled $0.00 in Q2 2025, maintaining a N/A margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $69.00M. Net income dropped to $21.00M, with EPS at $0.08. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan